ARTICLE | Company News
Bio-Technology General sales and marketing update
July 12, 1993 7:00 AM UTC
BTGC's BioLon, a ready-to-use syringe containing a solution of sodium hyaluronate, has been launched in Canada by Ophtapharma Canada Inc. The HA maintains the shape of the eye during surgery, BTGC sai...